This month’s boardroom activity across biotech, diagnostics, CROs, and digital health companies highlights a strategic push for scientific excellence, commercial acumen, and global leadersh
This month’s executive moves in the agency, consultancy, and investor sectors reflect a growing emphasis on strategic leadership, commercial expansion, and specialised expertise in life sci
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
